Numinus Wellness Inc
Change company Symbol lookup
Select an option...
NUMIF Numinus Wellness Inc
FBSI First Bancshares Inc (Missouri)
KGDEY Kingdee International Software Group Co Ltd
CMRA Comera Life Sciences Holdings Inc
ADI Analog Devices Inc
KEY KeyCorp
FNF Fidelity National Financial Inc
CTAQU Carney Technology Acquisition Corp. II
MUE BlackRock MuniHoldings Quality Fund II, Inc.
NC NACCO Industries Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Numinus Wellness Inc. is a Canada-based integrated mental wellness company that provides ketamine- and psychedelic-assisted therapies. The Company is engaged in the integrative health industries and operates through three divisions: Numinus Biosciences, Numinus Health and Mindspace Psychology Services. Numinus Bioscience provides services, including cultivation, analytical testing, product research and development, and ancillary services under its Health Canada licenses. The testing license allows the Company to test and analyze cannabis products from licensed producers, and the dealer’s license allows the Company to test, possess, buy and sell methylenedioxymethamphetamine (MDMA), psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline. Numinus Health and Mindspace Psychology Services operates centers located in Vancouver, British Columbia and Montreal, Quebec. The Company operates 13 wellness clinics, four clinical research facilities and a psychedelics research lab.

Price
Delayed
$0.2095
Day's Change
-0.0003 (-0.12%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.215
Day's Low
0.197
Volume
(Light)

Today's volume of 21,658 shares is on pace to be much lighter than NUMIF's 10-day average volume of 127,162 shares.

21,658
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

The risk of loss in trading futures can be substantial. Clients must consider all relevant risk factors, including their own personal financial situation, before trading. Margin and level 2 options approval or higher is required. Not all account owners will qualify.

Dividends are converted to USD using the current rate of exchange at the end of the business day on the day the dividend went EX. Earnings are converted to USD using the current rate of exchange at the end of the business day on the day earnings were announced.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.